Immunoassays are used to measure the presence and/or concentration of an analyte (protein, hormone, antibody). A main characteristic of immunoassays is their high specificity, resulting from the use of analyte specific antibodies. These can detect the analyte of interest at even low concentration.
Depending on the format, immunoassays use different detection signals to indicate the binding of the antibody to the analyte, each with its specific advantages. Streamline data interpretation is achieved with automation and rapid measurement of detection signals.
As part of its full range of clinical biomarker services, CellCarta offers three immunoassay platforms which can all be tailored to your needs: Olink®’s PEA technology, MSD®, and ELISA. Through consultation with our team of expert scientists we will help you pick the right platform for your sample analysis needs.
This unmatched high-multiplex technique allows for the quantification of protein biomarkers using minimal clinical sample volume (as low as 1 µL of blood), with exceptional sensitivity and specificity, while covering a broad dynamic range.
MSD® is a highly sensitive and multiplexed platform for cytokine/chemokine screening. It allows the measurement of up to ten analytes in each well of a 96- or 384-well plate using serum or plasma samples as small as 25 μL. MSD® offers up to 40 plex format and can be customized for specific cytokines/chemokines of interest.
ELISAs are well-established single-analyte assays that delivers robust and reliable data. With a high-throughput capacity, they provide quick and efficient monitoring of critical biomarkers.